Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Positron emission tomography imaging of inflammation and infection in children: an update
Published in: Seminars in Nuclear Medicine
Positron emission tomography (PET) has been used in pediatric oncology since the modality gained traction 20 years ago but has been used more sparingly in infectious and inflammatory diseases due to the ionizing radiation involved. However, more recent PET/CT systems allowing for the reduction of radiation dose have resulted in markedly more referrals, for these indications, over the past decade. Pediatric patients present unique challenges due to age-dependent physiology, nonspecific symptoms, and comorbidities, complicating diagnosis and limiting the utility of conventional imaging. [¹⁸F]-Fluorodeoxyglucose ([ 18F]FDG) PET/CT offers sensitive...
André H Dias, Marie Ø Fosbøl, Oleksandra V Ivashchenko, Flemming L Andersen, Ole L Munk, Riemer H J A Slart, Andor W J M Glaudemans, Lars C Gormsen
Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Fibroblast activation protein-targeted radionuclide therapy (FAP-TRT) has emerged as a novel strategy for modulating the tumour microenvironment (TME) by selectively eradicating FAP-expressing cancer-associated fibroblasts (CAFs). Although preclinical studies have demonstrated promising results across various tumour models using diverse radiolabelled FAP inhibitors, clinical translation remains limited by modest efficacy, short tumour retention, and highly heterogeneousresponses. This review aims to provide an overview of recent advances in radiopharmaceutical design to enhance tumour targeting and prolong retention. Furthermore, we summarise early clinical findings and ongoing trials, while emphasising the potential translational...
Validation of a Deep-Learning Coregistration Framework for Long-Axial-Field-of-View PET/CT Using Low-Radiation-Exposure Protocols Across Various Tracers
Published in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
The advent of long-axial-field-of-view (LAFOV) PET/CT systems has significantly improved whole-body imaging by providing higher sensitivity and extended torso coverage. However, PET/CT potential misalignment remains a challenge, potentially introducing artifacts and quantification errors. Moreover, PET protocols with reduced scanning duration and dose, as well as the use of ultra-low-dose CT (ULD-CT), are increasingly relevant in clinical practice and research. This study aimed to evaluate the robustness and generalizability of a deep-learning coregistration framework for PET/CT alignment using low-dose PET and ULD-CT across various tracers with a LAFOV system....
Standardization of infection [18F]FDG-PET/CT imaging protocols and reporting criteria.
Published in: Seminars in Nuclear Medicine
[ 18F]FDG-PET/CT (infection PET) has emerged as a key modality in the evaluation and management of patients with suspected or proven infection. Despite several recommendations addressing general preparation, acquisition, interpretation and reporting, infection PET/CT remains insufficiently standardized across indications and centers. This review provides a comprehensive overview of general and indication-specific aspects of infection PET and proposes clinically applicable suggestions to harmonize protocols, maximize the diagnostic performance and its contribution to patient management.
Ben F Bulten, Riemer H J A Slart, Andor W J M Glaudemans, Sören Hess, Erik H J G Aarntzen, Olivier Gheysens
The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons
Published in: Seminars in Nuclear Medicine
OBJECTIVE: The diagnosis of osteomyelitis (OM) remains a significant clinical challenge, often requiring a multimodality imaging approach to differentiate infection from non-infectious inflammatory conditions. This review focuses on primary and secondary osteomyelitis, with particular emphasis on fracture-related infections, sternal infections, and the assessment of dissemination of infection using nuclear medicine techniques, from established scintigraphic methods to advanced hybrid imaging and emerging technologies. FINDINGS: While three-phase bone scintigraphy remains a highly sensitive initial screening tool, its utility is limited by low specificity. White blood cell (WBC) scintigraphy, particularly when...
J Gatón-Ramírez, R H J A Slart, O Gheysens, E Noriega-Álvarez, A W J M Glaudemans